Literature DB >> 30005774

Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.

Arjun Menta1, Tamer M Fouad2, Anthony Lucci3, Huong Le-Petross4, Michael C Stauder5, Wendy A Woodward5, Naoto T Ueno6, Bora Lim7.   

Abstract

Inflammatory breast cancer (IBC) is a rare form of breast cancer that accounts for only 2% to 4% of all breast cancer cases. Despite its low incidence, IBC contributes to 7% to 10% of breast cancer caused mortality. Despite ongoing international efforts to formulate better diagnosis, treatment, and research, the survival of patients with IBC has not been significantly improved, and there are no therapeutic agents that specifically target IBC to date. The authors present a comprehensive overview that aims to assess the present and new management strategies of IBC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast changes; Clinical trials; Inflammatory breast cancer; Trimodality care

Mesh：

Year:  2018        PMID： 30005774     DOI： 10.1016/j.suc.2018.03.009

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  19 in total

1.  PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation.

Authors:  Anna R Michmerhuizen; Andrea M Pesch; Leah Moubadder; Benjamin C Chandler; Kari Wilder-Romans; Meleah Cameron; Eric Olsen; Dafydd G Thomas; Amanda Zhang; Nicole Hirsh; Cassandra L Ritter; Meilan Liu; Shyam Nyati; Lori J Pierce; Reshma Jagsi; Corey Speers
Journal:  Mol Cancer Ther       Date:  2019-08-14       Impact factor: 6.261

2.  Inflammatory breast cancer, trimodal treatment, and mortality: Does where you live matter?

Authors:  Theresa Relation; Yaming Li; James L Fisher; Allan Tsung; Bridget Oppong; Mariam F Eskander; Samilia Obeng-Gyasi
Journal:  Surgery       Date:  2021-11-30       Impact factor: 3.982

3.  Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.

Authors:  Lauren M Drapalik; Jonathan J Hue; Ashley Simpson; Mary Freyvogel; Lisa Rock; Robert R Shenk; Amanda L Amin; Megan E Miller
Journal:  Ann Surg Oncol       Date:  2022-08-08       Impact factor: 4.339

4.  ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer.

Authors:  J C Chen; Jose G Bazan; Samilia Obeng-Gyasi
Journal:  Ann Surg Oncol       Date:  2022-06-14       Impact factor: 4.339

5.  Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer.

Authors:  Ananya Gopika Nair; Vasily Giannakeas; John L Semple; Steven A Narod; David W Lim
Journal:  Ann Surg Oncol       Date:  2022-09-08       Impact factor: 4.339

6.  Integrated Analysis of Genomic and Transcriptomic Profiles Identified the Role of GTP Binding Protein-4 (GTPBP4) in Breast Cancer.

Authors:  Yiming Hu; Jiaheng Xie; Liang Chen; Qikai Tang; Wei Wei; Wenfeng Lin; Wang Du; Tinghong Xiang; Lu Yin; Jing Ji
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

7.  Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment.

Authors:  Hasan Karanlik; Neslihan Cabioglu; Adela Luciana Oprea; Ilker Ozgur; Naziye Ak; Adnan Aydiner; Semen Onder; Süleyman Bademler; Bahadir M Gulluoglu
Journal:  Breast Care (Basel)       Date:  2020-12-16       Impact factor: 2.268

8.  Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016.

Authors:  Daniel I Hoffman; Patricia Mae G Santos; Macy Goldbach; Luke J Keele; Neil K Taunk; Hannah S Bogen; Laura Burkbauer; Rachel C Jankowitz; Joshua Fosnot; Liza C Wu; Gary M Freedman; Julia C Tchou
Journal:  Ann Surg Oncol       Date:  2021-07-16       Impact factor: 5.344

9.  Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors.

Authors:  Kensuke Kaneko; Takuya Osada; Michael A Morse; William R Gwin; Joshua D Ginzel; Joshua C Snyder; Xiao-Yi Yang; Cong-Xiao Liu; Márcio A Diniz; Khaldon Bodoor; Philip F Hughes; Timothy Aj Haystead; H Kim Lyerly
Journal:  Commun Biol       Date:  2020-05-08

10.  Identification of Potential Key Genes and Pathways for Inflammatory Breast Cancer Based on GEO and TCGA Databases.

Authors:  Qing Lv; Yansong Liu; Hu Huang; Mingjie Zhu; Junqiang Wu; Dong Meng
Journal:  Onco Targets Ther       Date:  2020-06-12       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.